Oncolytic activity of naturally attenuated herpes-simplex virus HF10 against an immunocompetent model of oral carcinoma
Open Access
- 1 March 2021
- journal article
- research article
- Published by Elsevier in Molecular Therapy-Oncolytics
- Vol. 20, 220-227
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 36 references indexed in Scilit:
- Auditory and vestibular defects induced by experimental labyrinthitis following herpes simplex virus in miceActa Oto-Laryngologica, 2011
- Carrier cell-based delivery of replication-competent HSV-1 mutants enhances antitumor effect for ovarian cancerCancer Gene Therapy, 2010
- Apoptosis induction after herpes simplex virus infection differs according to cell type in vivoArchives of Virology, 2010
- Oncolytic activity of Sindbis virus in human oral squamous carcinoma cellsBritish Journal of Cancer, 2009
- A mouse model for oral squamous cell carcinomaJournal of Molecular Histology, 2009
- Animal Models of Cancer in the Head and Neck RegionClinical and Experimental Otorhinolaryngology, 2009
- Intratumoral injection of herpes simplex virus HF10 in recurrent head and neck squamous cell carcinomaActa Oto-Laryngologica, 2006
- Oral Cavity and Esophageal Carcinogenesis Modeled in Carcinogen-Treated MiceClinical Cancer Research, 2004
- Herpes Simplex Virus as an in Situ Cancer Vaccine for the Induction of Specific Anti-Tumor ImmunityHuman Gene Therapy, 1999
- VIRUSES WITH ONCOLYTIC PROPERTIES AND THEIR ADAPTATION TO TUMORSAnnals of the New York Academy of Sciences, 1952